Literature DB >> 28732818

Adherence to COPD treatment: Myth and reality.

Paola Rogliani1, Josuel Ora2, Ermanno Puxeddu1, Maria Gabriella Matera3, Mario Cazzola4.   

Abstract

COPD is a chronic disease in which effective management requires long-term adherence to pharmacotherapies but the level of adhesion to the prescribed medications is very low and this has a negative influence on outcomes. There are several approaches to detect non-adherence, such as pharmacy refill methods, electronic monitoring, and self-report measures, but they are all burdened with important limitations. Medication adherence in COPD is multifactorial and is affected by patients (health beliefs, cognitive abilities, self-efficacy, comorbidities, psychological profile, conscientiousness), physicians (method of administration, dosing regimen, polypharmacy, side effects), and society (patient-prescriber relationship, social support, access to medication, device training, follow-up). Patient-health care professional communication, especially that between patient and physician or pharmacist, is central to optimizing patient adherence. However, the most realistic approach is to keep in mind that non-adherence is always possible, indeed, probable.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adherence; COPD; Taxonomy

Mesh:

Substances:

Year:  2017        PMID: 28732818     DOI: 10.1016/j.rmed.2017.06.007

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  20 in total

1.  Self-reported COPD Medication Use and Adherence in the COPD Foundation Patient- Powered Registry Network.

Authors:  Cara B Pasquale; Radmila Choate; Gretchen McCreary; Richard A Mularski; William Clark; MaryEllen Houlihan; Elisha Malanga; Barbara P Yawn
Journal:  Chronic Obstr Pulm Dis       Date:  2021-10-28

2.  Primary non-adherence to inhaled medications measured with e-prescription data from Poland.

Authors:  Grzegorz Kardas; Michał Panek; Piotr Kuna; Przemysław Kardas
Journal:  Clin Transl Allergy       Date:  2020-10-07       Impact factor: 5.871

Review 3.  Doxofylline is not just another theophylline!

Authors:  Maria Gabriella Matera; Clive Page; Mario Cazzola
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-12-05

4.  The IARA Model as an Integrative Approach to Promote Autonomy in COPD Patients through Improvement of Self-Efficacy Beliefs and Illness Perception: A Mixed-Method Pilot Study.

Authors:  Andrea De Giorgio; Angelo Dante; Valeria Cavioni; Anna M Padovan; Desiree Rigonat; Francesca Iseppi; Giuseppina Graceffa; Francesca Gulotta
Journal:  Front Psychol       Date:  2017-10-05

Review 5.  Day and Night Control of COPD and Role of Pharmacotherapy: A Review.

Authors:  Alberto Braghiroli; Fulvio Braido; Alessio Piraino; Paola Rogliani; Pierachille Santus; Nicola Scichilone
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-06-04

Review 6.  Promoting Community Pharmacy Practice for Chronic Obstructive Pulmonary Disease (COPD) Management: A Systematic Review and Logic Model.

Authors:  Yuqi Hu; Dongning Yao; Carolina Oi Lam Ung; Hao Hu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-08-03

7.  Effects of a COPD self-management support intervention: a randomized controlled trial.

Authors:  Heidi B Bringsvor; Eva Langeland; Bjørg Frøysland Oftedal; Knut Skaug; Jörg Assmus; Signe Berit Bentsen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-11-08

8.  The Relationship Between the "Adherence Starts with Knowledge-20" Questionnaire and Clinical Factors in Patients with COPD: A Multi-Center, Cross-Sectional Study.

Authors:  Kaho Akimoto; Kuniaki Hirai; Tomohiro Matsunaga; Keisuke Kaneko; Hatsuko Mikuni; Tomoko Kawahara; Tomoki Uno; Akiko Fujiwara; Yoshito Miyata; Shin Ohta; Tetsuya Homma; Hideki Inoue; Fumihiro Yamaguchi; Sojiro Kusumoto; Shintaro Suzuki; Akihiko Tanaka; Hironori Sagara
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-12-04

9.  Chinese Medicine for Chronic Obstructive Pulmonary Disease: A Pilot Study on Patient Preferences.

Authors:  Shaonan Liu; Jiaqi Lai; Lei Wu; Xinfeng Guo
Journal:  Patient Prefer Adherence       Date:  2021-07-08       Impact factor: 2.711

10.  Optimizing COPD treatment in patients with lung- or head and neck cancer does not improve quality of life - a randomized, pilot, clinical trial.

Authors:  Magnus Gottlieb; Anders Mellemgaard; Kristoffer Marsaa; Nina Godtfredsen
Journal:  Eur Clin Respir J       Date:  2020-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.